Cited by 526Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis MechanismsAcute Ischemic Stroke Management

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis

Ginsburg, Katherine S., Liang, Matthew H., Newcomer, Laura, Goldhaber, Samuel Z., Schur, Peter H., Hennekens, Charles H., Stampfer, Meir J.·1992·Annals of Internal Medicine

DOI 10.7326/0003-4819-117-12-997

Open this paper in CoChat — free account

Abstract

Objective To determine whether the presence of anticardiolipin antibodies is a risk factor for ischemic stroke and venous thrombosis in healthy adult men. Design A nested, case-control study in a prospective cohort. Setting A nationwide study of physicians. Participants The study sample was drawn from the Physicians' Health Study, a randomized, double-blind, placebo-controlled trial of aspirin and beta-carotene in 22,071 male physicians. At entry, 68% of the participants submitted plasma samples that were subsequently frozen at -80 degrees C. During 60.2 months of follow-up, follow-up for nonfatal outcomes was 99.7% complete and ascertainment of fatal outcomes was 100% complete. We identified men with documented ischemic stroke, deep venous thrombosis of the leg, or pulmonary embolus and for whom a plasma sample was available. A control was matched by age, smoking history, and length of follow-up to each of the 100 patients with ischemic stroke and the 90 patients with deep venous thrombosis or pulmonary embolus. Measurements Plasma samples were assessed for IgG anticardiolipin antibodies by enzyme-linked immunosorbent assay. The mean anticardiolipin antibody titers of the case patients in the two diagnostic groups (ischemic stroke; venous thrombosis or pulmonary embolus) were compared with those of the control groups, and relative risks were calculated for patients in increasing percentile categories of anticardiolipin antibodies by conditional logistic regression. Results T…

Integrity signals

Registry

Crossref · 10.7326/0003-4819-117-12-997

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
Harris, E. N., Boey, M. L., Mackworth-Young, C. G., Gharavi, A. E., Patel, B. M., Loizou, S., & Hughes, G. R. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91267-9 · Cited by 1,383
Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
The “Primary” Antiphospholipid Syndrome
Asherson, R. A., Khamashta, M. A., Ordi, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 963
The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients
Alarcón-Segovia, D., Delezé, M., Oria, C. V., Sánchez‐Guerrero, J., Gómez-Pacheco, L., Cabiedes, J., Fernández, L. A. N., & de León, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 635
ARTERIAL THROMBOSIS, INTRAUTERINE DEATH AND "LUPUS" ANTICOAGULANT: DETECTION OF IMMUNOGLOBULIN INTERFERING WITH PROSTACYCLIN FORMATION
Carreras, L., Machin, S. J., Deman, R., DEFREYN, G., Vermylen, J., Spitz, B., & Assche, A. V. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92087-0 · Cited by 551
Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results.
Loizou, S., McCrea, J. D., Rudge, A. C., Reynolds, R., Boyle, C. C., & Harris, E. N. (1985) · PubMed Central · Cited by 549
Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia
Harris, E. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360230069012 · Cited by 546
Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health Study
The Steering Committee of the Physicians' Health Study Research Group (1988) · New England Journal of Medicine · doi:10.1056/nejm198801283180431 · Cited by 522

Show all 49 references

Research works printed but not linked: 15

Meyer O, 1987, J Rheum., 14, 502
Colaco C, 1983, Ann Rheum Dis., 42, 228
Harris E, 1985, J Clin Lab Immunol., 16, 1
Colaco C, 1985, Clin Exp Immunol., 59, 449
Harris E, 1987, Clin Exp Immunol., 68, 215
Hall S, 1984, J Rheum., 11, 846
Asherson R, 1989, Q J Med., 73, 1103
Cronin M, 1988, J Rheum., 15, 795
Klemp P, 1988, Clin Exp Immunol., 74, 254
Lavalle C, 1990, J Rheum., 17, 34
Coon W, 1976, Surg Gynecol Obstet., 143, 385
Hasselaar P, 1990, J Rheumatol., 17, 186
Loizou S, 1985, Clin Exp Immunol., 62, 738
Ruiz-Arguelles G, 1989, J Rheumatol., 16, 381
McNeil H, 1990, Clin Exp Rheumatol., 8, 525

Sorted by citations

Items 201–300 of 525

The Management of Stroke in Antiphospholipid Syndrome
Panichpisal, K., Rozner, E., & Levine, S. R. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-011-0223-5 · Cited by 36
Pathogenesis and Treatment of Atherosclerosis in Lupus
McMahon, M. A., & Skaggs, B. J. (2014) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2014.04.003 · Cited by 35
Antiphospholipid Antibodies in Children without and in Adults with and without Thrombophilia
Siemens, H.-J. G., Gutsche, S., Brückner, S., Bucsky, P., & Katus, H. A. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(99)00241-8 · Cited by 35
Neurological Dysfunction Associated with Antiphospholipid Syndrome: Histopathological Brain Findings of Thrombotic Changes in a Mouse Model
Ziporen, L., Polak-Charcon, S., Korczyn, A. D., Goldberg, I., Afek, A. B., Kopolovic, J., Chapman, J., & Shoenfeld, Y. (2004) · Journal of Immunology Research · doi:10.1080/10446670410001670526 · Cited by 35
Transient ischemic attack and stroke in systemic lupus erythematosus
Timlin, H., & Petri, M. (2013) · Lupus · doi:10.1177/0961203313497416 · Cited by 35
Primary Antiphospholipid Syndrome with Moyamoya-Like Vascular Changes
Booth, F. A., Yanofsky, R., Ross, I. B., Lawrence, P. H., & Oen, K. (1999) · Pediatric Neurosurgery · doi:10.1159/000028830 · Cited by 34
Hypercoagulable states and strokes
Matijevic, N., & Wu, K. K. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0011-2 · Cited by 34
LUPUS ANTICOAGULANTS AND ANTIPHOSPHOLIPID ANTIBODIES
Thiagarajan, P., & Shapiro, S. S. (1998) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70048-4 · Cited by 34
Differential Diagnosis of Central Nervous System Manifestations of the Antiphospholipid Antibody Syndrome
Brey, R. L. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0426 · Cited by 34
Association Between Anticardiolipin Antibodies and Recurrent Cardiac Events in Patients With Acute Coronary Syndrome
Gürlek, A., Özdöl, Ç., Pamir, G., Dinçer, İ., Tutkak, H., & Oral, D. (2005) · International Heart Journal · doi:10.1536/ihj.46.631 · Cited by 33
Testing for and Clinical Significance of Anticardiolipin Antibodies
Reddel, S., & Krilis, S. A. (1999) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.6.6.775-782.1999 · Cited by 32
The antiphospholipid-protein syndrome
Cines, D. B., & McCrae, K. R. (1995) · Journal of Clinical Immunology · doi:10.1007/bf01540898 · Cited by 33
Atherosclerosis in autoimmune diseases
Matsuura, E., Kobayashi, K., & Lopez, L. R. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0009-1 · Cited by 32
Antiphospholipid antibiodies: a critical review of the literature
Lim, W., & Crowther, M. A. (2007) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282a4a65f · Cited by 32
Treatment of antiphospholipid syndrome
Radin, M., Cecchi, I., Rubini, E., Foddai, S. G., Barinotti, A., Menegatti, E., Roccatello, D., & Sciascia, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108597 · Cited by 32
The Antiphospholipid Thrombosis Syndromes: A Common Multidisciplinary Medical Problem
Bick, R. L. (1997) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602969700300409 · Cited by 32
Antiphospholipid syndrome
(2011) · SpringerReference · doi:10.1007/springerreference_37528 · Cited by 32
Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review
Cheng, C., Cheng, G.-Y., Denas, G., & Pengo, V. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100788 · Cited by 36
Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Valle, P. D., Crippa, L., Garlando, A. M., Pattarini, E., Safa, O., D’Angelo, S., & D’Angelo, A. (1999) · PubMed · Cited by 31
New targeted therapies for treatment of thrombosis in antiphospholipid syndrome
Pierangeli, S. S., Vega-Ostertag, M. E., & González, E. B. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000506 · Cited by 31
Acute postoperative biventricular failure associated with antiphospholipid antibody syndrome
Dornan, R. I. P. (2004) · British Journal of Anaesthesia · doi:10.1093/bja/aeh116 · Cited by 30
IgG and IgM isotypes of anti-cardiolipin and anti-β 2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events
Locht, H., & Wiik, A. S. (2005) · Clinical Rheumatology · doi:10.1007/s10067-005-1166-x · Cited by 29
The Journey of Antiphospholipid Antibodies From Cellular Activation to Antiphospholipid Syndrome
Willis, R., Gonzalez, E. B., & Brasier, A. R. (2015) · Current Rheumatology Reports · doi:10.1007/s11926-014-0485-9 · Cited by 29
The immunology of atherothrombosis in the antiphospholipid syndrome: Antigen presentation and lipid intracellular accumulation
Matsuura, E., Kobayashi, K., Matsunami, Y., & Lopez, L. R. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.12.018 · Cited by 29
Prothrombotic states associated with retinal venous occlusion in young adults
El-Asrar, A. A., Al-Momen, A., Al-Amro, S. A., Gader, A. G. M. A., & Tabbara, K. F. (1997) · International Ophthalmology · doi:10.1007/bf00175260 · Cited by 29
Hughes syndrome crosses boundaries
Ruiz‐Irastorza, G., Khamashta, M. A., & Hughes, G. R. V. (2002) · Autoimmunity Reviews · doi:10.1016/s1568-9972(01)00005-2 · Cited by 28
Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases
D'Olhaberriague, L., Levine, S. R., Salowich‐Palm, L., Tanné, D., Sawaya, K. L., Aurora, T. K., Perry, M., Day, M., Spencer, H. J., & Schultz, L. (1998) · Neurology · doi:10.1212/wnl.51.5.1376 · Cited by 28
Recurrent acute transverse myelopathy associated with anticardiolipin antibodies.
Campi, A., Filippi, M., Comı, G., & Scotti, G. (1998) · PubMed Central · Cited by 27
Recomendaciones de la Sociedad Española de Reumatología sobre síndrome antifosfolípido primario. Parte I: Diagnóstico, evaluación y tratamiento
Cáliz, R., Fontecha, P. D. D. C., Galindo-Izquierdo, M., Longo, F. J. L., Zamora, M. Á. M., Santamaría, A., Pliego, O. A., Lozano, M. J. C., Beltrán, M. P. D., Carmona, L., et al. (2019) · Reumatología Clínica · doi:10.1016/j.reuma.2018.11.003 · Cited by 26
Treatment of Risk Factors to Prevent Stroke
Aoki, J., & Uchino, K. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0054-0 · Cited by 25
Antiphospholipid Syndrome: Review
Sammaritano, L. R. (2005) · Southern Medical Journal · doi:10.1097/01.smj.0000166748.90089.65 · Cited by 26
Antiphospholipid Antibody Testing: Which Are Most Useful for Diagnosis?
Bertolaccini, M. L., & Hughes, G. R. V. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.05.001 · Cited by 26
Thrombophilia and Stroke
Green, D. (2003) · Topics in Stroke Rehabilitation · doi:10.1310/l9kd-n5n8-69x0-08qk · Cited by 26
Optimal Duration of Oral Anticoagulant Therapy in Venous Thromboembolism
Schulman, S. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657614 · Cited by 26
The anti-phospholipid antibody syndrome (Hughes syndrome): therapeutic aspects
Cuadrado, M. J., & Khamashta, M. A. (2000) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.1999.0083 · Cited by 25
Which Antiphospholipid Antibodies Should Be Measured in the Antiphospholipid Syndrome?
Galli, M. (2000) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000054164 · Cited by 25
Anatomic distribution of venous thrombosis in patients with antiphospholipid antibody: imaging findings.
Provenzale, J. M., & Ortel, T. L. (1995) · American Journal of Roentgenology · doi:10.2214/ajr.165.2.7618558 · Cited by 25
Anticorps anticardiolipine, ischémie cérébrale et hémorragie surrénalienne chez un nouveau-né
Teysier, G., Gautheron, V., Absi, L., Galambrun, C., Raynaud-Ravni, C., & Jc, L. P. (1995) · Archives de Pédiatrie · doi:10.1016/0929-693x(96)81285-1 · Cited by 25
Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome
Kokosi, M. A., Lams, B., & Agarwal, S. (2019) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.06.001 · Cited by 26
Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease
Erkkilä, A. T., Närvänen, O., Lehto, S., JUUSITUPA, M., & Ylä‐Herttuala, S. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.02.026 · Cited by 24
Prothrombotic states that predispose to stroke
Hiatt, B. K., & Lentz, S. R. (2002) · Current Treatment Options in Neurology · doi:10.1007/s11940-002-0009-1 · Cited by 23
Clinical presentations and vascular histopathology in autopsied patients with systemic lupus erythematosus and anticardiolipin antibodies.
Sipek-Dolnicar, A., Hojnik, M., Božič, B., Vizjak, A., Rozman, B., & Ferluga, D. (2002) · PubMed · Cited by 24
Impact of plasma homocysteine and prothrombin G20210A on primary antiphospholipid syndrome
Ames, P. R. J., Margaglione, M., Tommasino, C., Bossone, A., Iannaccone, L., & Brancaccio, V. (2001) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200112000-00012 · Cited by 24
A Review of Hereditary and Acquired Coagulation Disorders in the Aetiology of Ischaemic Stroke
de Lau, L. M. L., Leebeek, F. W. G., de Maat, M. P. M., Koudstaal, P. J., & Dippel, D. W. J. (2010) · International Journal of Stroke · doi:10.1111/j.1747-4949.2010.00468.x · Cited by 24
A re‐appraisal of the normal cut‐off assignment for anticardiolipin IgM tests
Budd, R. C., HARLEY, E., Quarshie, A., Henderson, V. J., Harris, E. N., & Pierangeli, S. S. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02134.x · Cited by 23
Surgical treatment for encapsulating peritoneal sclerosis.
Kawanishi, H. (2002) · PubMed · Cited by 23
Dermatologic lupus: Hopkins lupus cohort
Petri, M. (1998) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/s1085-5629(98)80017-5 · Cited by 22
Monocyte Tissue Factor Induction by Activation of β2-Glycoprotein-I-Specific T Lymphocytes Is Associated with Thrombosis and Fetal Loss in Patients with Antiphospholipid Antibodies
Visvanathan, S., Geczy, C. L., Harmer, J. A., & McNeil, H. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2258 · Cited by 22
Retracted
Thrombophilic states
Martinelli, I., Passamonti, S. M., & Bucciarelli, P. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4087-0.00071-1 · Cited by 21
Thrombophilic risk factors in patients with severe carotid atherosclerosis
Marcucci, R., Sofi, F., Fedi, S., Lari, B., Sestini, I., Cellai, A. P., Pulli, R., Pratesi, G., Pratesi, C., Gensini, G. F., et al. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01173.x · Cited by 21
Antiphospholipid Syndrome: State of the Art with Emphasis on Laboratory Evaluation
Greaves, M. (2000) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000054159 · Cited by 20
Recurrent Thrombosis in Patients with Deep Vein Thrombosis and/or Venous Thromboembolism Associated with Anticardiolipin Antibodies
de Godoy, J. M. P., de Godoy, M. F., & Braile, D. M. (2006) · Angiology · doi:10.1177/000331970605700111 · Cited by 23
Clinical Trials on Antiphospholipid Syndrome: What is Being Done and What is Needed?
Barbui, T., & Finazzi, G. (1994) · Lupus · doi:10.1177/096120339400300419 · Cited by 21
Antiphospholipid Syndrome: General Features
Godfrey, T., & D’Cruz, D. P. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3666-8_2 · Cited by 21
Immunomodulation of Vascular Diseases: Atherosclerosis and Autoimmunity
Shi, G. (2010) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2010.01.028 · Cited by 20
Anti-phospholipid Antibodies and Smoking: An Overview
Binder, S. R., & Litwin, C. M. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8565-4 · Cited by 21
Monitoring systemic lupus erythematosus in standard clinical care
Petri, M. (2007) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.01.003 · Cited by 20
Mechanism of action of β2-glycoprotein I-dependent lupus anticoagulants
Amout, J., & Vermylen, J. (1998) · Lupus · doi:10.1177/096120339800700206 · Cited by 20
Catastrophic antiphospholipid syndrome in a community-acquired methicillin-resistant Staphylococcus aureus infection: A review of pathogenesis with a case for molecular mimicry
Martin, E., Winn, R. E., & NUGENT, K. M. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.09.023 · Cited by 19
Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies
Sairam, S., Baethge, B. A., & McNearney, T. A. (2003) · Clinical Rheumatology · doi:10.1007/s10067-002-0660-7 · Cited by 19
PROGNOSIS IN ANTIPHOSPHOLIPID SYNDROME
Amigo, M. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70227-1 · Cited by 19
The Antiphospholipid Syndrome.
Gattorno, M. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.6.349b · Cited by 19
Chapter 2 Epidemiology of the Antiphospholipid Syndrome
Mehrani, T., & Petri, M. (2009) · Technical report · doi:10.1016/s1571-5078(08)00402-9 · Cited by 18
Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia
Öztürk, M. A., Haznedaroğlu, İ. C., Turgut, M., & Göker, H. (2004) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960401000201 · Cited by 19
Antiphospholipid syndrome presenting as cerebral venous sinus thrombosis: a case series and a review
Shlebak, A. A. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203077 · Cited by 19
Lung Disease in Antiphospholipid Syndrome
Maioli, G., Calabrese, G., CAPSONI, F., Gerosa, M., Meroni, P. L., & Chighizola, C. B. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1683994 · Cited by 18
Antiphospholipid antibodies in patients with retinal vascular occlusions
Giordano, N. G., Senesi, M., Battisti, E., Traversi, C., Mattii, G., Palumbo, F., & Gennari, C. (1998) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.1998.760129.x · Cited by 18
Antiphospholipid antibody associated thrombosis: A consensus for treatment?
McCrae, K. (1996) · Lupus · doi:10.1177/096120339600500602 · Cited by 18
Laboratory Diagnosis of Antiphospholipid Syndromes
Reyes, H., Dearing, L. D., Bick, R. L., Shoenfeld, Y., & Peter, J. B. (1995) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30345-7 · Cited by 18
Therapeutic Potential of Toleragens in the Management of Antiphospholipid Syndrome
Cockerill, K. A., Iverson, G. M., Jones, D. S., & Linnik, M. D. (2004) · BioDrugs · doi:10.2165/00063030-200418050-00002 · Cited by 18
The Antiphospholipid Syndrome
Park, K. W. (2004) · International Anesthesiology Clinics · doi:10.1097/00004311-200404230-00006 · Cited by 17
Immunogenic Oxidized Low-density Lipoprotein/β2-glycoprotein I Complexes in the Diagnostic Management of Atherosclerosis
Lopez, L. R., Kobayashi, K., Matsunami, Y., & Matsuura, E. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-008-8096-8 · Cited by 17
Antiphospholipid Antibodies and the Risk of Thromboembolic Events in Valvular Heart Disease
Bulckaen, H., Puisieux, F. L., Bulckaen, E., Pompéo, C. D., Bouillanne, O., Watel, A., Fauchais, A. L., de Groote, P., & Millaire, A. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.3.294 · Cited by 17
Classification and Epidemiology of the Antiphospholipid Syndrome
Petri, M. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50004-8 · Cited by 17
The Antiphospholipid and Thrombosis (APL-T) Syndromes: Clinical and Laboratory Correlates
Bick, R. L., & Ancypa, D. (1995) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30344-5 · Cited by 17
Primary antithrombotic prevention in carriers of antiphospholipid antibodies without systemic autoimmune disorders
Finazzi, G. (2012) · Lupus · doi:10.1177/0961203312437440 · Cited by 15
Cardiovascular events in patients with antiphospholipid antibodies: Strategies of prevention
Tufano, A., Guida, A., Minno, M. N. D. D., Gregorio, A. M. D., Cerbone, A. M., & Minno, G. D. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.10.016 · Cited by 14
Platelet and endothelial activation are requisites for the development of antiphospholipid syndrome
Garcia, E. D. R., Rodriguez, C. S., Rodríguez-Martorell, J., Serrano, A., & González, J. A. G. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.010694 · Cited by 14
Guidelines for the Primary Prevention of Stroke A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of these guidelines as an educational tool for neurologists. Endorsed by the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, and the Preventive Cardiovascular Nurses Association
Meschia, J. F., Bushnell, C., Boden-Albala, B. M., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Fornage, M., Goldstein, L. B., et al. (2014) · Cited by 15
Value of anticardiolipin antibodies for monitoring disease activity in systemic lupus erythematosus and other rheumatic diseases
Buttgereit, F., Grünewald, T., Schüler-Maué, W., Burmester, G. R., & Hiepe, F. (1997) · Clinical Rheumatology · doi:10.1007/bf02247796 · Cited by 14
High Titer of Anticardiolipin Antibody Is Associated with First-Ever Ischemic Stroke in Taiwan
Lien, L., Chen, W., Chiu, H., Pan, W., Chen, J.-R., & Bai, C. (2006) · Cerebrovascular Diseases · doi:10.1159/000094008 · Cited by 14
Accelerated Atheroma in the Antiphospholipid Syndrome
Matsuura, E., Kobayashi, K., Tabuchi, M., & Lopez, L. R. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.05.006 · Cited by 14
Manifestations neurologiques associées aux anticorps antiphospholipides. Ou que restetil du neurolupus ?
HACHULLA, E., Leys, D., Deleume, J. F., Pruvo, J., & Devulder, B. (1995) · La Revue de Médecine Interne · doi:10.1016/0248-8663(96)80676-x · Cited by 14
Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I
McDonnell, T. C. R., Artım-Esen, B., Wincup, C., Ripoll, V. M., Isenberg, D. A., Giles, I., Rahman, A., & Pericleous, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02244 · Cited by 13
The neurology of lupus
Hanly, J. G., & İnanç, M. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117419 · Cited by 13
Atherogenic Antiphospholipid Antibodies in Antiphospholipid Syndrome
Kobayashi, K., Lopez, L. R., & Matsuura, E. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1422.052 · Cited by 13
Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No
Finazzi, G. (2008) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0169-4 · Cited by 13
Stroke Prevention in Patients with Antiphospholipid Antibodies
Brey, R. L. (1994) · Lupus · doi:10.1177/096120339400300418 · Cited by 13
Treatment of the antiphospholipid antibody syndrome: Progress in the last five years?
Petri, M. (2000) · Current Rheumatology Reports · doi:10.1007/s11926-000-0088-5 · Cited by 13
Thromboprophylaxis in Non-Surgical Patients:Who, When and How?
Gallus, A. S., Nurmohammed, M., Kearon, C., & Prins, M. H. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022408 · Cited by 13
Is There A Place for Adjuvant Therapy in IVF?
Segev, Y., Carp, H., Auslender, R., & Dirnfeld, M. (2010) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3181dbc53f · Cited by 12
The Therapeutic Value of Laboratory Testing for Hypercoagulable States in Secondary Stroke Prevention
Kalaria, C., & Kittner, S. J. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.01.003 · Cited by 12
Traitement du syndrome des anticorps antiphospholipides
Saadoun, D., Pietté, J. C., Wahl, D. G., & Costedoat-Chalumeau, N. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.01.007 · Cited by 12
Comparative antiplatelet activity of COX1 NSAIDS versus aspirin, encompassing regimen simplification and gastroprotection: a call for a controlled study
Rothschild, B. M. (2011) · Reumatismo · doi:10.4081/reumatismo.2004.89 · Cited by 12
Antiphospholipid Antibodies, Brain Infarcts, and Cognitive and Motor Decline in Aging (ABICMA): Design of a Community-Based, Longitudinal, Clinical-Pathological Study
Arvanitakis, Z., Brey, R. L., Rand, J. H., Schneider, J. A., Leurgans, S. E., Yu, L., Buchman, A. S., Arfanakis, K., Fleischman, D. A., Boyle, P. A., et al. (2012) · Neuroepidemiology · doi:10.1159/000342761 · Cited by 12
Complement-fixing activity of anticardiolipin antibodies in patients with and without thrombosis
Shinzato, M. M., Bueno, C., Viana, V. S. T., Borba, E. F., Gonçalves, C. R., & Bonfá, E. (2005) · Lupus · doi:10.1191/0961203305lu2252oa · Cited by 11
The antiphospholipid syndrome
Franchini, M., & Veneri, D. (2005) · Hematology · doi:10.1080/10245330500141309 · Cited by 12
Alterations of cerebral blood flow and antiphospholipid antibodies in patients with systemic lupus erythematosus
Postiglione, A., Chiara, S. D., Soricelli, A., Oriente, A., Ruocco, A., Spadaro, G., Montefusco, S., Marone, G., & Genovese, A. (1998) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990050015 · Cited by 12
Antiphospholipid antibodies: immunological aspects
Roubey, R. A. S. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.02.010 · Cited by 12
Biomarkers for cardiovascular risk assessment in autoimmune diseases
Teixeira, P. C., Ferber, P. C., Vuilleumier, N., & Cutler, P. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400125 · Cited by 11

Authors: Ginsburg, K. S., Liang, M. H., Newcomer, L., Goldhaber, S. Z., Schur, P. H., Hennekens, C. H., & Stampfer, M. J.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Liang, Matthew H.
Goldhaber, Samuel Z.
Hennekens, Charles H.
Stampfer, Meir J.
Venue: Annals of Internal Medicine
Publisher: American College of Physicians
Published: 1992-12-15
Volume: 117
Issue: 12
Pages: 997-1002
ISSN: 0003-4819 (ISSN-L)
1539-3704
DOI: 10.7326/0003-4819-117-12-997
OpenAlex: W1491481195
Cited by: 526
References: 49
Citations by year: 2025: 2 · 2024: 7 · 2023: 5 · 2022: 1 · 2021: 8 · 2020: 8 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 7 · 2015: 7 · 2014: 10 · 2013: 15 · 2012: 16
FWCI: 16.25
Type: journal article
Language: en
Open access: closed
Locations: Annals of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (R01CA042182, CA 42182)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P60AR036308, AR-36308, AR-07530, T32AR007530)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords: anticardiolipin antibodies, ischemic stroke, venous thrombosis, deep vein thrombosis, pulmonary embolism, thrombophilia, risk factors, IgG, male physicians, Physicians' Health Study, aspirin, beta-carotene, anticoagulation, stroke prevention, antithrombotic therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Brain Ischemia, Enzyme-Linked Immunosorbent Assay, Humans, Male, Middle Aged, Prospective Studies, Pulmonary Embolism, Risk Factors, Statistics as Topic, Thrombophlebitis, Case-Control Studies, Antibodies, Anticardiolipin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks